# THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

> **NCT02732704** · NA · ACTIVE_NOT_RECRUITING · sponsor: **JenaValve Technology, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Aortic Regurgitation

## Interventions

- **DEVICE:** JenaValve Pericardial TAVR System

## Key facts

- **NCT ID:** NCT02732704
- **Lead sponsor:** JenaValve Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-20
- **Primary completion:** 2022-08-29
- **Final completion:** 2027-09-29
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732704, "THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02732704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*